Publications & working papers

Beyond the label: Regulatory arbitrage in pharmaceutical market entry with Jennifer Kao. Awarded NIHCM Foundation Research Grant

From private to public: Pharmaceutical R&D and hiring patterns post-IPO with Jennifer Kao

Innovation and cross-market spillovers in “big” firms with Matthew Grennan and Mara Lederman

One product, many patents: Imperfect intellectual property rights in the pharmaceutical industry. Selected for presentation at NBER Summer Institute (Innovation)

Drug repurposing during the COVID-19 pandemic: Lessons for expediting drug development and access with Wesley Greenblatt and Jennifer Kao, Health Affairs (2023)

Research in progress

What gets commercialized? The role of venture capital in disruptive innovations

Standing on the patents of giants: Concentrated intellectual property rights and cumulative innovation

Competing risks and “missing” medical innovation with Alexander Olssen

Other writing

Industry, universities, and intellectual property, white paper prepared for the NBER-IFS International Network on the Value of Medical Research